|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Randomized phase II comparison of dose-intense gem-citabine:thirty-minute infusion and fixed dose rate in-fusion in patients with pancreatic adenocarcinoma显示文摘 | Tempero M Plunkett W Ruiz Van Haperen V | 2003 | JClin Oncol2003，21，34： | 1 |
| 2 | Bile acids, ornithine decarboxylase, and cell proliferation in colon cancer: a review显示文摘 | TEMPERO M | 1986 | Dig Dis1986，4，1： | 1 |
| 3 | Randomized pahse 2 comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma显示文摘 | Tempero M Plunkett W Ruiz Van Haperen V | 2003 | J clin oncol2003，21，18： | 1 |
| 4 | Pancreatic cancer treatment and research:an international expert panel discussion显示文摘 | Tempero MA Berlin J Ducreux M | 2011 | Ann Oncol2011，22，7： | 1 |
| 5 | Pancreatic cancer treatment and research: an international expert panel discussion显示文摘 | Tempero MA Berlin J Ducreux M | 2011 | Ann Oncol2011，22，7： | 1 |
| 6 | Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers显示文摘 | DARWlSH M TEMPERO K KIRBY M | 2005 | Clin Pharmacokinet2005，44，12： | 1 |
| 7 | Randomized phase Ⅱ comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocar- cinoma显示文摘 | Tempero M Plunkett W Ruiz VHV | 2003 | J Clin Oneol2003，21，18： | 1 |
| 8 | Randomized phase Ⅱ comparison of dose -intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma显示文摘 | Plunkett W Ruiz Van Haperen V | 2003 | J Clin Oncol2003，21，18： | 1 |
| 9 | Randomized phase Ⅱ comparison of dose-intense gemcitabine:thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma 显示文摘 | Tempero M Plunkett W Ruiz VHV | 2003 | J Clin Oncol2003，21，18： | 1 |
| 10 | Randomized phase Ⅱ comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma 显示文摘 | Tempero M Plunkett W Ruiz Van Haperen V | 2003 | J Clin Oncol2003，21，18： | 1 |
| 11 | Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1080 pg versus oral transmucosal fentanyl citrate 1600 pg and dose proportionality of FEBT 270 to 1300 pg: A single -dose, randomized, open - label, three - period study in healthy adult volunteers 显示文摘 | Darwish M Tempero K Kirby M | 2006 | Clin Ther2006，28，5： | 1 |
| 12 | Randomized phase II comparison of dose-intense gemcitabine:Thirty-minute infusion and fixed dose rate infusion in patient with pancreatic adenocarcinoma显示文摘 | Tempero M Plunkett W Ruiz Van Haperen V | 2003 | J Clin Oncol2003，21，： | 1 |
| 13 | Lymphatic malformations: review of current treatment显示文摘 | PERKINS J A MANNING S C TEMPERO R M | 2010 | Otolaryngol Head Neck Surg2010，142，： | 1 |
| 14 | Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers显示文摘 | Darwish M Tempero K Kirby M | 2005 | Clin Pharmacokinet2005，44，： | 1 |
| 15 | Randomized phase Ⅱtrial in metastatic pancreatic adenocarcinoma显示文摘 | Tempero M Plunkett W Ruizan Haperen V et el | | 0，，： | 1 |
| 16 | AGA technical review on the epidemiology,diagnosis,and treatment of pancreatic ductal adenocarcinoma显示文摘 | Dimagno E P Reber H A Tempero M A | 1999 | Gastroenterolgy1999，117，： | 1 |
| 17 | Randomized Phase Ⅱ comparison of dose-intense g(e)mcitabine:thirty-minute infusion anti fixed dose rate infusion in patients with pancreatic adenocarcinoma显示文摘 | Tempero M Phmkett W Ruiz Van Haperen V | 2003 | J Clin Oncol2003，21，18： | 1 |
| 18 | Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1080 pg versus oral transmucosal fentanyl citrate 1600 pg and dose proportionality of FEBT 270 to 1300 microg: a single - dose, randomized, open- label, three- period study in healthy adult volunteers显示文摘 | Darwish M Tempero K Kirby M | 2006 | Clin Ther2006，28，5： | 1 |
| 19 | Randomized phase Ⅱ comparison of dose-intense pemcitabine: Thirtyminute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma 显示文摘 | Tempero M Plunkett W Haperen VR | 2003 | J Clin Oncol2003，，18： | 1 |
| 20 | Randomized phase Ⅱ comparison of dose-intense gemcitabine:Thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma显示文摘 | Tempero M Plunkett W Ruiz Van Haperen V | 2003 | J Clin One2003，21，18： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员